220 related articles for article (PubMed ID: 25753532)
1. Tuning IL-2 signaling by ADP-ribosylation of CD25.
Teege S; Hann A; Miksiewicz M; MacMillan C; Rissiek B; Buck F; Menzel S; Nissen M; Bannas P; Haag F; Boyer O; Seman M; Adriouch S; Koch-Nolte F
Sci Rep; 2015 Mar; 5():8959. PubMed ID: 25753532
[TBL] [Abstract][Full Text] [Related]
2. T regulatory lymphocytes in type 1 diabetes: Impaired CD25 expression and IL-2 induced STAT5 phosphorylation in pediatric patients.
Parackova Z; Kayserova J; Danova K; Sismova K; Dudkova E; Sumnik Z; Kolouskova S; Lebl J; Stechova K; Sediva A
Autoimmunity; 2016 Dec; 49(8):523-531. PubMed ID: 27560779
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
[TBL] [Abstract][Full Text] [Related]
4. CD25 and Protein Phosphatase 2A Cooperate to Enhance IL-2R Signaling in Human Regulatory T Cells.
Ding Y; Yu A; Tsokos GC; Malek TR
J Immunol; 2019 Jul; 203(1):93-104. PubMed ID: 31085588
[TBL] [Abstract][Full Text] [Related]
5. PTD-hFOXP3 protein acts as an immune regulator to convert human CD4(+)CD25(-) T cells to regulatory T-like cells.
Liu X; Xu X; Lin X; Tian Y; Ji B; Xia S; Xu S; Yin Q; Zhang M; Jiao Z; Wang S; Xu H; Shao Q
J Cell Biochem; 2012 Dec; 113(12):3797-809. PubMed ID: 22806628
[TBL] [Abstract][Full Text] [Related]
6. [The STAT5 signaling in the expression of alpha-subunit of interleukin-2 receptor in human blood lymphocytes].
Mitiushova EV; Shatrova AN; Zenin VV; Aksenov ND; Marakhova II
Tsitologiia; 2013; 55(6):421-9. PubMed ID: 25509109
[TBL] [Abstract][Full Text] [Related]
7. Feedback loop of immune regulation by CD4+CD25+ Treg.
Jung YJ; Seoh JY
Immunobiology; 2009; 214(4):291-302. PubMed ID: 19327546
[TBL] [Abstract][Full Text] [Related]
8. CD25 shedding by human natural occurring CD4+CD25+ regulatory T cells does not inhibit the action of IL-2.
Pedersen AE; Lauritsen JP
Scand J Immunol; 2009 Jul; 70(1):40-3. PubMed ID: 19522766
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-7 optimizes FOXP3+CD4+ regulatory T cells reactivity to interleukin-2 by modulating CD25 expression.
Simonetta F; Gestermann N; Bloquet S; Bourgeois C
PLoS One; 2014; 9(12):e113314. PubMed ID: 25485946
[TBL] [Abstract][Full Text] [Related]
10. Sustained in vivo signaling by long-lived IL-2 induces prolonged increases of regulatory T cells.
Bell CJ; Sun Y; Nowak UM; Clark J; Howlett S; Pekalski ML; Yang X; Ast O; Waldhauer I; Freimoser-Grundschober A; Moessner E; Umana P; Klein C; Hosse RJ; Wicker LS; Peterson LB
J Autoimmun; 2015 Jan; 56():66-80. PubMed ID: 25457307
[TBL] [Abstract][Full Text] [Related]
11. Low-Zone IL-2 Signaling: Fusion Proteins Containing Linked CD25 and IL-2 Domains Sustain Tolerogenic Vaccination
DeOca KB; Moorman CD; Garcia BL; Mannie MD
Front Immunol; 2020; 11():541619. PubMed ID: 33072087
[TBL] [Abstract][Full Text] [Related]
12. Acute Lipopolysaccharide-Induced Inflammation Lowers IL-2R Signaling and the Proliferative Potential of Regulatory T Cells.
Hsiung S; Moro A; Ban Y; Chen X; Savio AS; Hernandez R; Malek TR
Immunohorizons; 2020 Dec; 4(12):809-824. PubMed ID: 33334814
[TBL] [Abstract][Full Text] [Related]
13. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y
Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562
[TBL] [Abstract][Full Text] [Related]
14. Functional Modulation of Regulatory T Cells by IL-2.
Moon BI; Kim TH; Seoh JY
PLoS One; 2015; 10(11):e0141864. PubMed ID: 26529512
[TBL] [Abstract][Full Text] [Related]
15. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
Bianchini R; Bistoni O; Alunno A; Petrillo MG; Ronchetti S; Sportoletti P; Bocci EB; Nocentini G; Gerli R; Riccardi C
Eur J Immunol; 2011 Aug; 41(8):2269-78. PubMed ID: 21557210
[TBL] [Abstract][Full Text] [Related]
16. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
[TBL] [Abstract][Full Text] [Related]
17. Type 1 diabetes-associated IL2RA variation lowers IL-2 signaling and contributes to diminished CD4+CD25+ regulatory T cell function.
Garg G; Tyler JR; Yang JH; Cutler AJ; Downes K; Pekalski M; Bell GL; Nutland S; Peakman M; Todd JA; Wicker LS; Tree TI
J Immunol; 2012 May; 188(9):4644-53. PubMed ID: 22461703
[TBL] [Abstract][Full Text] [Related]
18. IL-2 signaling and CD4+ CD25+ Foxp3+ regulatory T cells.
Turka LA; Walsh PT
Front Biosci; 2008 Jan; 13():1440-6. PubMed ID: 17981641
[TBL] [Abstract][Full Text] [Related]
19. Cytokine therapy with interleukin-2/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+ regulatory T cells and attenuates development and progression of atherosclerosis.
Dinh TN; Kyaw TS; Kanellakis P; To K; Tipping P; Toh BH; Bobik A; Agrotis A
Circulation; 2012 Sep; 126(10):1256-66. PubMed ID: 22851544
[TBL] [Abstract][Full Text] [Related]
20. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY
Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]